Latest / Stock Movers / Snowflake Jumps, Hewlett Packard Slides, and Ultragenyx Sinks as Rare Disorder Drug Fails Late Stage Trial
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio.
- 0:06Speaker 2: News.
- 0:08Speaker 1: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 1: in the stock market. Harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:18Speaker 2: the move today. We can do that with Bloomberg's Carmen Reineke.
- 0:21Speaker 2: She's Deputy Team Leader for U.S. Equities joining us here
- 0:23Speaker 2: in studio. Carmen, what are you looking at today?
- 0:25Speaker 1: Let's look a little.
- 0:26Speaker 3: Bit more at Snowflake. So this is ticker S-N-O-W. Shares
- 0:30Speaker 3: are really surging today. They're up 22% right now. This
- 0:33Speaker 3: is the most since May. So this company reported earnings,
- 0:38Speaker 3: second quarter results beat expectations, and raised its full year
- 0:41Speaker 3: forecast for product revenue. Analysts were really bullish on this company,
- 0:45Speaker 3: and we saw a lot of price target upgrades following
- 0:49Speaker 3: this report. I think it's really important to note here
- 0:51Speaker 3: that this is one of the few software companies that's
- 0:53Speaker 3: really sort of bucked the trend. We've seen a lot
- 0:55Speaker 3: of volatility in software this year, and this is up 72%
- 0:59Speaker 3: so far this year. It's on track for its best
- 1:01Speaker 3: year ever. So Snowflake really showing, you know, solid, solid
- 1:05Speaker 3: results and no fears here, at least, of AI disruption.
- 1:08Speaker 1: All right, let's go from software to hardware because HP Enterprise,
- 1:13Speaker 1: Hewlett Packard Enterprise, is also reported.
- 1:15Speaker 3: It did, and a little bit of a different outcome here.
- 1:17Speaker 3: So ticker HPE, shares are down 6.5% right now following
- 1:21Speaker 3: its results. This is the worst day since August 19th,
- 1:26Speaker 3: so a few weeks there. So sales didn't meet expectations
- 1:29Speaker 3: from investors. This stock has also had a pretty considerable
- 1:33Speaker 3: run up this year. So we could just be seeing
- 1:35Speaker 3: a little bit of, you know, the buy the sort
- 1:36Speaker 3: of buy the rumor, sell the news catalyst here. The
- 1:39Speaker 3: company did boost its revenue outlook for the current fiscal year.
- 1:43Speaker 3: But it also said that sales are being held back
- 1:45Speaker 3: by a continued lack of components. That's from the CEO
- 1:51Speaker 3: on the call. So something we've seen across the industry.
- 1:53Speaker 1: Sounds familiar.
- 1:54Speaker 3: Yes.
- 1:54Speaker 2: Yeah. We're going to talk to Bloomberg Intelligence Ujin Ho
- 1:57Speaker 2: in just a moment later on this hour, and he'll
- 1:58Speaker 2: give us some more detail on HPE.
- 2:02Speaker 3: Ultragenyx?
- 2:04Speaker 1: Ultragenyx.
- 2:05Speaker 3: I also hope that I'm pronouncing that correctly. I'm not 100% sure.
- 2:08Speaker 3: The ticker is RARE. So this stock is down 45%
- 2:12Speaker 3: right now. This is a record one-day drop, and it
- 2:16Speaker 3: looks like it is.
- 2:17Speaker 2: Oh, sorry.
- 2:18Speaker 3: It's actually just missing right now, a record one-day drop.
- 2:21Speaker 3: But at the intraday low, it was. And it's at
- 2:23Speaker 3: the lowest since 2014. So this is a biotech company.
- 2:27Speaker 3: And it said one of it, you know, I'm actually
- 2:29Speaker 3: not going to try to say the drug name.
- 2:31Speaker 1: Those are really difficult.
- 2:32Speaker 3: So an experimental drug to treat a rare genetic disorder
- 2:36Speaker 3: failed to meet a primary endpoint of change from the baseline.
- 2:39Speaker 3: So investors really selling off here. And at least five
- 2:44Speaker 3: brokerages downgraded their rating on the stock. So seeing a
- 2:48Speaker 3: lot of bearish sentiment.
- 2:49Speaker 2: But, you know, there's a hedge fund trader somewhere. who
- 2:53Speaker 2: is short this stock.
- 2:54Speaker 1: Oh, yeah.
- 2:54Speaker 2: That's his or her job. I'm a biotech trader at
- 2:58Speaker 2: XYZ Hedge Fund. It's my job to pick winners and losers.
- 3:01Speaker 2: And this person guessed right.
- 3:02Speaker 3: So you hear me.
- 3:05Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:09Speaker 1: us throughout the day for the latest roundup of companies
- 3:12Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:16Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:21Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:24Speaker 1: Business app.